Matthieu Coutet

Matthieu brings more than 15 years of experience in venture capital and operations, having spent a decade in tech transfer as Head of Company Creation at Inserm Transfert (Paris, France) and managing partner at Inserm Transfert Initiative. He handled investments in 14 seed-stage companies including Enyo Pharma, Eyevensys, Sensorion and Inotrem. He also served as VP of Operations & Business Development at two French biotechnology start-ups, TherAchon (sold to Pfizer) and Annapurna Therapeutics (merged with Adverum Biotechnology). Matthieu co-founded AdBio Partners with Alain Huriez in 2016.
Matthieu not only brings a wealth of experience in early-stage investor management, and financial and operational strategies but also a strong network of researchers, entrepreneurs and technology transfer officers with whom he has forged significant partnerships.